IL2 and diffuse large B-cell lymphoma: In the case of diffuse large B cell lymphoma (DLBCL), this remains true, where myeloid interactions produce a complex chemokine and cytokine milieu including CCL5, IL-2, IL-12, and IL-10 which recruit additional cells to propagate malignancy, providing survival and differentiation signals for cancerous B cells.